You have not yet registered? Get your account for free.
Forgot Password? We will send you a reset link
10 December 2019
SYNIMMUNE GmbH Reports Interim Results of First-in-Human Study of Fc-Optimized Antibody FLYSYN for the Treatment of Acute Myeloid Leukemia
30 May 2017
SYNIMMUNE GmbH Initiates First-in-Human Study of Fc-Optimized Antibody FLYSYN for the Treatment of Acute Myeloid Leukemia